2023 ACA Philadelphia Program Book_153rd Congress of Correction

advance hepatitis C elimination, mechanisms to lower testing and treatment costs and data systems needed to build an effective hepatitis C elimination program. Learning Objectives: • Demonstrate knowledge of how hepatitis C testing and treatment in corrections advances national hepatitis C elimination goals. • Describe the most effective hepatitis C screening policies, list potential partners that can expand testing and identify mechanisms to lower testing costs. • Describe approaches to treatment prioritization, reference provider training resources, identify mechanisms and partners to lower DAA costs and describe methods to incorporate data platforms to inform improvements. Moderator: Marti Kay Sherry , Health Services Administrator, Michigan Department of Corrections, Lansing, Michigan Speakers: Jeffrey Fisher , RN, Assistant Deputy Commissioner, Massachusetts Department of Correction, Milford, Massachusetts; Nathan Furukawa , M.D., MPH, Senior Advisor for Hepatitis C Elimination, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia; Robert Lawrence , M.D., M.Ed., M.A., Chief Medical Officer, Alaska Department of Corrections, Anchorage, Alaska

• Workshop will outline new trends that would be beneficial to the understanding of ever changing correctional field of medicine. Moderator: Nanette Larson , Deputy Commissioner, Client Support Services, Minnesota Department of Corrections, Saint Paul, Minnesota Speakers: Harbans Deol , D.O., Ph.D., Deputy Chief Medical Officer, VitalCore Health Strategies, Topeka, Kansas; Jerome Greenfield , Health Services Administrator, Iowa Department of Corrections, Des Moines, Iowa C-2I Hepatitis C: Strategies to Expand Hepatitis C Testing and Treatment in Corrections Members (CE, Y CE, CME) Track: Medical Room 204-B Highly effective, well-tolerated, oral-only treatments for hepatitis C with direct acting antiviral (DAA) agents have been available for nearly a decade. Although curative treatment with DAAs is recommended for essentially everyone with hepatitis C, comprehensive hepatitis C testing and treatment in correctional settings has been challenged by various constraints. Despite these constraints, several DOCs have implemented innovative approaches to expand hepatitis C testing and treatment. The session will review the most effective testing and treatment strategies, key partnerships to

WORKSHOPS

Saturday, Aug. 12 ▼ 10–11:30 a.m.

ACA 153 rd Congress of Correction | Philadelphia — 129